On May 12, President Trump issued an Executive Order (EO) on drug pricing: “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients.” The EO requires a 30-day government negotiation with drug companies...more
6/10/2025
/ Drug Pricing ,
Executive Orders ,
Government Agencies ,
Medicaid ,
Medicare ,
Pharmaceutical Industry ,
Popular ,
Prescription Drugs ,
Rulemaking Process ,
Statutory Interpretation ,
Trump Administration
On May 12, 2025, the Consumer Financial Protection Bureau (CFPB) announced a sweeping withdrawal of 67 guidance documents issued since the CFPB’s inception, signaling a marked shift in its regulatory approach. This move...more
5/14/2025
/ Consumer Financial Protection Bureau (CFPB) ,
Corporate Counsel ,
Enforcement Actions ,
Executive Orders ,
Final Rules ,
Financial Services Industry ,
Popular ,
Proposed Rules ,
Regulatory Reform ,
Regulatory Requirements ,
Rulemaking Process ,
Trump Administration
On April 9, 2025, President Trump issued a memorandum directing federal agencies to begin repealing regulations deemed “clearly unlawful,” particularly those invalidated or undermined by recent Supreme Court rulings such as...more
On March 12, the Federal Communications Commission (FCC) launched a new deregulatory initiative through a Public Notice titled “In Re: Delete, Delete, Delete.” In this Public Notice, the FCC solicits public comments on...more
After weeks of emptying the shelves at the Consumer Financial Protection Bureau (CFPB) with dozens of enforcement actions, new rules, proposed regulations and guidance, President Donald Trump fired CFPB Director Rohit Chopra...more
The Federal Trade Commission (FTC) is one of the independent agencies expected to undergo considerable changes in rulemaking priorities once President-elect Trump enters office. Chairwoman Lina Khan is expected to step down...more